Table 2.
Probation Department Leader Responses on Perceptions of Barriers to OUD Medications
| Agree/strongly agree | Neither agree/disagree | Disagree/strongly disagree | ||
|---|---|---|---|---|
| Barrier | N | % | % | % |
| Lack of access to medical personnel with expertise. | 22 | 72.7 | 13.6 | 13.6 |
| Agency has concerns about the cost of MAT/not enough funding. | 22 | 50.0 | 18.2 | 31.8 |
| Need for guidance. | 22 | 40.9 | 36.4 | 22.7 |
| Not enough institutional knowledge of medications and how they work. | 22 | 36.4 | 22.7 | 40.9 |
| Regulations prohibit use at the agency. | 22 | 22.7 | 45.5 | 31.8 |
| Agency has liability concerns (e.g. potential medication diversion/misuse). | 22 | 18.2 | 45.5 | 36.4 |
| Agency favors medicine-free treatment. | 22 | 9.1 | 63.6 | 27.3 |
| Clinical staff at your agency objects. | 23 | 8.7 | 73.9 | 17.4 |
| Administration in your agency objects. | 23 | 4.3 | 87.0 | 8.7 |